Shift Bioscience Raises $16M to Advance Cell Simulation AI Platform https://t.co/VxIb9MYmNd https://t.co/ITfH4X6dzb

We have raised $16M in seed funding to advance our #AI cell simulation platform for identifying safe #rejuvenation genes—a key step in developing therapeutics for #age-related diseases. Read the full press release here https://t.co/qHZ0Q0fwo8 https://t.co/qCS7BvAHQu

Shift Bio lands $16m to identify safe #rejuvenation genes... @ShiftBioscience’s platform identifies gene-factors likely to rejuvenate cells without triggering the risks associated with using #Yamanakafactors. #longevity #ShiftBioscience @dives86 https://t.co/1U9pIW9aYE